NYSE:GRDN Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis $50.39 +0.96 (+1.94%) As of 03:36 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Guardian Pharmacy Services Stock (NYSE:GRDN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GRDN alerts:Sign Up Key Stats Today's Range$49.20▼$50.8050-Day Range$39.08▼$50.0152-Week Range$26.34▼$50.80Volume156,821 shsAverage Volume432,815 shsMarket Capitalization$3.19 billionP/E Ratio42.96Dividend YieldN/APrice Target$45.57Consensus RatingModerate Buy Company Overview Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States. Fred Burke, a company co-founder, serves as its chief executive officer.AI Generated. May Contain Errors. Read More Guardian Pharmacy Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreGRDN MarketRank™: 1.64436199814 of 5 starsGuardian Pharmacy Services scored higher than 33% of companies evaluated by MarketBeat, and ranked 740th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingModerate Buy Consensus RatingGuardian Pharmacy Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on no strong buy ratings, 9 buy ratings, 1 hold rating, and no sell ratings.Downside RiskGuardian Pharmacy Services has a consensus price target of $45.57, representing about 9.6% downside from its current price of $50.39.Amount of Analyst CoverageGuardian Pharmacy Services has only been the subject of 3 research reports in the past 90 days.Read more about Guardian Pharmacy Services' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth12.71% Earnings GrowthEarnings for Guardian Pharmacy Services are expected to grow by 12.71% in the coming year, from $1.18 to $1.33 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Guardian Pharmacy Services is 42.96, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.98.Price to Earnings Ratio vs. SectorThe P/E ratio of Guardian Pharmacy Services is 42.96, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.16.Price to Earnings Growth RatioGuardian Pharmacy Services has a PEG Ratio of 2.58. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGuardian Pharmacy Services has a P/B Ratio of 11.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.19% of the float of Guardian Pharmacy Services has been sold short.Short Interest Ratio / Days to CoverGuardian Pharmacy Services has a short interest ratio ("days to cover") of 6.64.Change versus previous monthShort interest in Guardian Pharmacy Services has recently decreased by 7.50%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardian Pharmacy Services does not currently pay a dividend.Dividend GrowthGuardian Pharmacy Services does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.42 News SentimentGuardian Pharmacy Services has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Guardian Pharmacy Services this week, compared to 2 articles on an average week. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.Percentage Held by Insiders32.96% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsGuardian Pharmacy Services has minimal institutional ownership at this time.Read more about Guardian Pharmacy Services' insider trading history. Receive GRDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GRDN Stock News HeadlinesGuardian Pharmacy Services (NYSE:GRDN) Stock Rating Upgraded by Wall Street ZenNovember 14 at 1:15 AM | americanbankingnews.comIs Guardian Pharmacy Services (GRDN) Stock Reasonable After Raised Guidance?November 9, 2026 | uk.finance.yahoo.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 17 at 1:00 AM | Profits Run (Ad)Guardian Pharmacy Services (GRDN) Jumped, But What Is Behind The Move?November 9, 2026 | finance.yahoo.comGuardian Pharmacy forecasts $1.44B-$1.46B 2026 revenue and $136M-$138M adjusted EBITDA as it expands in Texas and AlabamaNovember 6, 2026 | seekingalpha.comGuardian Pharma (GRDN) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | finance.yahoo.comEarnings Flash (GRDN) Guardian Pharmacy Services, Inc. Reports Q3 Revenue $371.1M, vs. FactSet Est of $365.8MNovember 5, 2026 | marketscreener.comMGuardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year GuidanceNovember 5, 2026 | businesswire.comSee More Headlines GRDN Stock Analysis - Frequently Asked Questions How have GRDN shares performed this year? Guardian Pharmacy Services' stock was trading at $30.01 at the start of the year. Since then, GRDN stock has increased by 67.9% and is now trading at $50.3890. How were Guardian Pharmacy Services' earnings last quarter? Guardian Pharmacy Services, Inc. (NYSE:GRDN) released its quarterly earnings results on Thursday, November, 5th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.02. The business earned $371.07 million during the quarter, compared to analysts' expectations of $365.76 million. Guardian Pharmacy Services had a trailing twelve-month return on equity of 30.29% and a net margin of 5.13%. Read the conference call transcript. When did Guardian Pharmacy Services IPO? Guardian Pharmacy Services (GRDN) raised $102 million in an IPO on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities acted as the underwriters for the IPO. Who are Guardian Pharmacy Services' major shareholders? Top institutional shareholders of Guardian Pharmacy Services include State Street Corp (1.22%), First Trust Advisors LP (0.95%), Bessemer Group Inc. (1.14%) and Boston Partners (0.83%). Insiders that own company stock include William E Bindley, Thomas J Salentine Jr, Fred Burke, Kendall Forbes, John Ackerman, Equity Fund LP Cardinal, David K Morris and Steven D Cosler. View institutional ownership trends. How do I buy shares of Guardian Pharmacy Services? Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/05/2026Today11/17/20262026 Stephens Annual Investment Conference | NASH202611/18/2026Citi Annual Global Healthcare Conference 202612/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (13m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 GRDN's financial health is in the Green zone, according to TradeSmith. GRDN has been in this zone for over 13 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:GRDN Previous SymbolNYSE:GRDN CIK1802255 Webguardianpharmacy.com Phone(404) 810-0089FaxN/AEmployees3,600Year Founded2004Price Target and Rating Average Price Target for Guardian Pharmacy Services$45.57 High Price Target$52.00 Low Price Target$36.00 Potential Upside/Downside-9.1%Consensus RatingModerate Buy Rating Score (0-4)2.90 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$1.17 Trailing P/E Ratio42.91 Forward P/E Ratio37.68 P/E Growth2.58Net Income$49.22 million Net Margins5.13% Pretax Margin7.22% Return on Equity30.29% Return on Assets16.86% Debt Debt-to-Equity RatioN/A Current Ratio1.65 Quick Ratio1.33 Sales & Book Value Annual Sales$1.45 billion Price / Sales2.19 Cash Flow$1.28 per share Price / Cash Flow39.21 Book Value$4.42 per share Price / Book11.34Miscellaneous Outstanding Shares63,320,000Free Float42,450,000Market Cap$3.17 billion OptionableOptionable Beta0.06 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NYSE:GRDN) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored“IMPERIUM”: The #1 investment of 2027Could a strange new bio-chip be the most transformative innovation in history? Elon Musk calls it "amazing." A...Banyan Hill Publishing | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.